The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis

OBJECTIVE: We compared the expression levels of Müllerian inhibiting substance (MIS)/anti-Müllerian hormone type II receptor (AMHRII) in uterine myoma and adenomyosis to evaluate the possibility of using MIS/anti-Müllerian hormone (AMH) as a biological regulator or therapeutic agent in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Shin Young, Moon, Hye Min, Lee, Min Kyoung, Chung, Youn Jee, Song, Jae Yen, Cho, Hyun Hee, Kim, Mee Ran, Kim, Jang Heub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780307/
https://www.ncbi.nlm.nih.gov/pubmed/29372159
http://dx.doi.org/10.5468/ogs.2018.61.1.127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780307/
https://www.ncbi.nlm.nih.gov/pubmed/29372159
http://dx.doi.org/10.5468/ogs.2018.61.1.127

Ejemplares similares